JPMorgan Chase & Co. grew its stake in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Free Report) by 24.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 34,633 shares of the company’s stock after acquiring an additional 6,769 shares during the quarter. JPMorgan Chase & Co. owned about 0.19% of Nature’s Sunshine Products worth $472,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in the stock. Wasatch Advisors LP grew its position in Nature’s Sunshine Products by 23.2% in the 3rd quarter. Wasatch Advisors LP now owns 696,184 shares of the company’s stock worth $9,482,000 after purchasing an additional 131,174 shares during the period. Barclays PLC boosted its stake in shares of Nature’s Sunshine Products by 51.8% in the 3rd quarter. Barclays PLC now owns 35,602 shares of the company’s stock worth $485,000 after buying an additional 12,152 shares during the last quarter. Franklin Resources Inc. grew its holdings in shares of Nature’s Sunshine Products by 4.3% in the third quarter. Franklin Resources Inc. now owns 20,744 shares of the company’s stock worth $270,000 after acquiring an additional 856 shares during the period. XTX Topco Ltd purchased a new stake in Nature’s Sunshine Products during the second quarter valued at $180,000. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Nature’s Sunshine Products by 4.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 786,966 shares of the company’s stock worth $11,860,000 after purchasing an additional 34,996 shares during the period. 79.40% of the stock is currently owned by institutional investors.
Nature’s Sunshine Products Price Performance
Shares of NATR stock opened at $14.83 on Wednesday. Nature’s Sunshine Products, Inc. has a 1 year low of $10.81 and a 1 year high of $21.72. The firm has a fifty day moving average price of $15.23 and a 200-day moving average price of $14.48. The company has a market cap of $274.06 million, a price-to-earnings ratio of 16.85 and a beta of 0.96.
About Nature’s Sunshine Products
Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Featured Stories
- Five stocks we like better than Nature’s Sunshine Products
- How Investors Can Find the Best Cheap Dividend Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- What Does the Future Hold for Eli Lilly?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Want to see what other hedge funds are holding NATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Free Report).
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.